SCHEMBL1925178

SCHEMBL1925178

NC(=O)c1[nH]cc(CCC(=O)O)c1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 13/20 0.49
PDGFRB P09619 5/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
FLT3 P36888 6/20 0.47
AURKB Q96GD4 2/20 0.47
NTRK1 P04629 2/20 0.47
RET P07949 2/20 0.47
NTRK3 Q16288 2/20 0.47
NTRK2 Q16620 2/20 0.47
LTK P29376 1/20 0.47
CDK8 P49336 1/20 0.47
MAPK14 Q16539 1/20 0.47
KIT P10721 5/20 0.46
CSF1R P07333 4/20 0.46
FLT1 P17948 4/20 0.46
LCK P06239 3/20 0.46
FLT4 P35916 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1925429 0.90 RIPK1 (0.46) KDRPDGFRBCA12CA1CA2
SCHEMBL1925334 0.90 EPHX2 (0.48) KDRCA12CA1CA2CA9
SCHEMBL1924020 0.86 CDK8 (0.43) KDRFLT3AURKBNTRK1RET
SCHEMBL1923967 0.86 MEN1 (0.51) KDRPDGFRBFLT3AURKBNTRK1
SCHEMBL1923687 0.86 CA12 (0.57) KDRPDGFRBCA12CA1CA2
SCHEMBL1925039 0.86 RIPK1 (0.44) KDRPDGFRBCA12CA1CA2
SCHEMBL1925337 0.85 PKM (0.47) KDRPDGFRBCA12CA1CA2
SCHEMBL1924035 0.84 CA12 (0.53) KDRPDGFRBCA12CA1CA2
SCHEMBL1923690 0.84 CA12 (0.55) KDRPDGFRBCA12CA1CA2
SCHEMBL1924576 0.84 CA12 (0.55) KDRPDGFRBCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP claimed